Page 7 - Genomic Sciences News Today

Joel Dudley opens AAPS biotechnology conference with talk examining current economic environment for biotechnology firm

The National Institute for Clinical Excellence (NICE) has published new guidelines for the best surgery for some women who have advanced ovarian cancer. Maximal cytoreductive surgery is a major operation that aims to remove all visible disease when t

The combination of olaparib and the investigational ATR inhibitor ceralasertib induced antitumor responses in children and adolescents with DNA repair-deficient tumors, according to phase 1 results of the AcSé-ESMART trial.The data, presented at American Association for Cancer Research Annual Meeting, also showed ceralasertib (AZD6738, AstraZeneca) plus olaparib (Lynparza, AstraZeneca) — a

The combination of PARP and ATR inhibition with olaparib and ceralasertib was tolerable but showed limited efficacy in pediatric patients with advanced malignancies harboring DNA replication stress and DNA repair deficiencies, according to findings from arm N of the phase 1/2 AcSé-ESMART trial.

Washington, DC (PRWEB) April 10, 2023 -- The Society for RNA Therapeutics is pleased to announce the members of its charter board of directors. The mission of

Programme aims to sequence the DNA of one million Emiratis, leading to more personalised treatments and a better understanding of the causes of disease

The largest study of its kind also demonstrated that the risk is shared across ethnicities. A multi-center study, led by the Icahn School of Medicine at Mount Sinai, has uncovered two previously unknown genes that are associated with schizophrenia. Furthermore, the study uncovered a third gene that

Washington, Mar 17 (Prensa Latina) A multi-center study, led by researchers at the Icahn School of Medicine at Mount Sinai, has identified two previously unknown genes linked to schizophrenia as well as a third gene that carries heightened risk for both schizophrenia and autism.

Researchers have identified genes that carry the risk for schizophrenia, an advance that may lead to new therapeutics.Schizophrenia is among the most serious mental illnesses. It occurs in about 1 out of every 100 people, and affects how they ...

Researchers have identified three genes that carry the risk for schizophrenia, an advance that may lead to new therapeutics.